Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Biscaglia

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Journal of the American Heart Association|July 4, 2025
Antiplatelet Therapy in Myocardial Bridge: Insights From the RIALTO RegistryRenzo Laborante, Giuseppe Ciliberti, Gaetano Rizzo, et al.
Cardiology Journal|August 13, 2016
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registryYoichi Imori, Fabrizio D'Ascenzo, Tommaso Gori, et al.
American Heart Journal|August 22, 2020
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trialSimone Biscaglia, Vincenzo Guiducci, Andrea Santarelli, et al.
American Heart Journal|August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCIRaffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Cardiovascular Diabetology|April 14, 2026
Diabetes does not attenuate the benefit of physiology-guided complete revascularization in older patients with myocardial infarctionAlberto Sarti, Filippo Maria Verardi, Caterina Cavazza, et al.
Circulation. Cardiovascular Quality and Outcomes|June 18, 2024
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only StrategyGianluca Campo, Vincenzo Guiducci, Javier Escaned, et al.
The New England Journal of Medicine|August 29, 2025
Multidomain Rehabilitation for Older Patients with Myocardial InfarctionElisabetta Tonet, Andrea Raisi, Silvia Zagnoni, et al.
Circulation|September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-AnalysisGianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
Heart (British Cardiac Society)|February 25, 2021
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplastyCarlo Tumscitz, Annamaria Di Cesare, Marco Balducelli, et al.
JACC. Cardiovascular Interventions|October 25, 2025
Renal Function-Stratified Comparison of Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and Multivessel DiseaseAnna Cantone, Filippo Maria Verardi, Giuseppe Vadalà, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Journal of the American Heart Association|July 4, 2025
Antiplatelet Therapy in Myocardial Bridge: Insights From the RIALTO RegistryRenzo Laborante, Giuseppe Ciliberti, Gaetano Rizzo, et al.
Cardiology Journal|August 13, 2016
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registryYoichi Imori, Fabrizio D'Ascenzo, Tommaso Gori, et al.
American Heart Journal|August 22, 2020
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trialSimone Biscaglia, Vincenzo Guiducci, Andrea Santarelli, et al.
American Heart Journal|August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCIRaffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Cardiovascular Diabetology|April 14, 2026
Diabetes does not attenuate the benefit of physiology-guided complete revascularization in older patients with myocardial infarctionAlberto Sarti, Filippo Maria Verardi, Caterina Cavazza, et al.
Circulation. Cardiovascular Quality and Outcomes|June 18, 2024
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only StrategyGianluca Campo, Vincenzo Guiducci, Javier Escaned, et al.
The New England Journal of Medicine|August 29, 2025
Multidomain Rehabilitation for Older Patients with Myocardial InfarctionElisabetta Tonet, Andrea Raisi, Silvia Zagnoni, et al.
Circulation|September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-AnalysisGianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
Heart (British Cardiac Society)|February 25, 2021
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplastyCarlo Tumscitz, Annamaria Di Cesare, Marco Balducelli, et al.
JACC. Cardiovascular Interventions|October 25, 2025
Renal Function-Stratified Comparison of Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and Multivessel DiseaseAnna Cantone, Filippo Maria Verardi, Giuseppe Vadalà, et al.
Pageof 18